Measure selection for an electronic patient-reported outcome (ePRO) system for CAR T-cell therapy patients: a modified Delphi consensus studyResearch in context

Summary: Background: Chimeric Antigen Receptor (CAR) T-cell therapies are effective for treating haematological cancers but carry risks of toxicity and substantial symptom burden. Patient-reported outcomes (PROs) could significantly enhance clinical management for patients undergoing these treatmen...

Повний опис

Бібліографічні деталі

Автори:	Sarah E. Hughes, Foram Khatsuria, Christel McMullan, Karen L. Shaw, Anita Walker, Francesca Kinsella, David Burns, Olalekan L. Aiyegbusi, Elin Haf Davies, John Ansell, Evelyn Chakera, Charles Craddock, Alastair Denniston, Rebecca Lloyd, Paul Ferguson, Ronjon Chakraverty, Melanie Calvert
Формат:	Artigo
Мова:	Inglês
Опубліковано:	Elsevier 2025-06-01
Серія:	EClinicalMedicine
Предмети:	Delphi Chimeric antigen receptor T-cell therapy Patient-reported outcome ePRO Digital health
Онлайн доступ:	http://www.sciencedirect.com/science/article/pii/S2589537025001889
Теги:	Додати тег Немає тегів, Будьте першим, хто поставить тег для цього запису!